Dr. Nicole Lurie: HHS, Mapp Biopharmaceutical Partner for Anti-Ebola Drug Development
Mapp Biopharmaceutical has landed an 18-month, $24.9 million contract with the Department of Health and Human Services to further develop ZMapp, an antibody drug designed to treat the Ebola virus. HHS’ Biomedical Advanced Research and Development Authority will provide financial, preclinical and manufacturing support to Mapp with the goal of obtaining U.S. regulatory approval for […] More